Precirix raised €80M in a Series B round in Mar 2022. The company is based in Brussels, Belgium. Investors in the round: BioMed Partners, Forbion Capital Partners, Gimv and 6 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €80M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
